JPRN-UMIN000014072招募中1 期
A phase I/II clinical study of expanded autologous NK cell combined with rituximab-based chemotherapy in patients with CD20 positive B-cell lymphoma - A phase I/II clinical study of expanded autologous NK cell combined with rituximab-based chemotherapy in patients with B-cell lymphoma
Department of Hematology, Tokyo Women's Medical University0 个研究点目标入组 10 人开始时间: 2014年6月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with active infections 2. Patients with severe complications 3. Pregnant or lactating women 4. Patients with history of severe allergy 5. Patients medicated with the immunosuppressive agents 6. Inappropriate patients for this study judged by the physicians
研究者
相似试验
已完成
1 期
se of stem cells for treatment of chronic kidney diseaseChronic Kidney Disease.Hypertensive renal diseaseIRCT201509031031N17Department of Regenerative Biomedicine, Cell Science Research Center, Royan Institute for Stem Cell10
终止
1 期
A clinical trial of adoptive T-cell immunotherapy for patients with Epstein-Barr virus-associated nasopharyngeal carcinoma.Metastatic nasopharyngeal carcinomaCancer - Head and neckACTRN12613000866707QIMR Berghofer Medical Research Institute18
已完成
1 期
Immune cell therapy for patients with COVID-19 related pneumonia using allogenic ex vivo NK cellsIRCT20200621047859N2Motamed Cancer Institute15
招募中
2 期
A single-arm, open-label, phase 2 study of autologous CD34+ stem cells-selected transplantation for severe systemic sclerosisSevere systemic sclerosisJPRN-UMIN000028381Department of Clinical Immunology and Rheumatology/Infectious Disease, Kyushu University Graduate school of Medicine12
进行中（未招募）
2 期
A clinical trial of autologous stem cell transplantation for severe systemic sclerosissystemic sclerosisJPRN-jRCTc071190041Akashi Koichi12